40 results
F-3
SCNI
Scinai Immunotherapeutics Ltd
30 Jan 24
Shelf registration (foreign)
4:19pm
, retirement, or other disposition of the Securities made by a U.S. paying agent or other U.S. intermediary will generally be reported to the IRS
424B3
SCNI
Scinai Immunotherapeutics Ltd
2 Jan 24
Prospectus supplement
8:24am
of dividends with respect to the Securities and the proceeds from the sale, retirement, or other disposition of the Securities made by a U.S. paying agent
F-1/A
SCNI
Scinai Immunotherapeutics Ltd
22 Dec 23
Registration statement (foreign) (amended)
9:11am
Reporting
Payments of dividends with respect to the Securities and the proceeds from the sale, retirement, or other disposition of the Securities
F-1
emekw rtzzmb5
30 Oct 23
Registration statement (foreign)
4:59pm
424B5
x4259un
19 Sep 23
Prospectus supplement for primary offering
10:03am
6-K
EX-99.1
o4tmuvysah xywrem
12 Jul 23
Report of Foreign Private Issuer
12:00am
10-K
bjqef0n0t8guq
17 Apr 23
Annual report
4:06pm
424B4
5jf1y
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
ggzqv6hztl jgoq3
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
F-1
gjbqykb6e07ub4zn3ynl
29 Sep 22
Registration statement (foreign)
9:22am
424B5
ikpdvlw v8lw8f2
28 Dec 21
Prospectus supplement for primary offering
5:20pm
424B5
vpuh80
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K
EX-99.1
bgn8h2jormztyp
22 Nov 21
Report of Foreign Private Issuer
6:05am
6-K
EX-99.1
g7xy4yemnssd2
4 Mar 21
Report of Foreign Private Issuer
1:01pm